How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Vitamin D3 Powder Market
- By Source: Lanolin-derived Vitamin D3, Fish Oil-derived Vitamin D3, Lichen-derived Vegan Vitamin D3, Synthetic Vitamin D3
- By Form: Micronized Powder, Granulated Powder, Spray-dried Powder, Encapsulated Powder
- By Application: Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Animal Feed
- By Purity Grade: Food Grade, Pharmaceutical Grade, Feed Grade
- By Packaging Type: Bulk Packaging, Retail Packaging, Industrial Packaging
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Lanolin-derived Vitamin D3 leads By Source at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 287 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Vitamin D3 Powder Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Source 4
Form 4
Application 4
Purity Grade 3
Packaging Type 3
Companies profiled
DSM Nutritional Products
Kemin Industries
Fermenta Biotech Ltd.
Hubei Guangji Pharmaceutical Co. Ltd.
Jiangsu Yabang Dyestuff Co. Ltd.
Zhejiang NHU Co. Ltd.
Jiangsu Kanion Pharmaceutical Co. Ltd.
BASF SE
CSPC Pharmaceutical Group Limited
Nutraceutical Corporation
Gnosis by Lesaffre
Jiangsu Yuyuan Pharmaceutical Co. Ltd.
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →DSM Nutritional Products
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Kemin Industries
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Fermenta Biotech Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Hubei Guangji Pharmaceutical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Jiangsu Yabang Dyestuff Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Zhejiang NHU Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Jiangsu Kanion Pharmaceutical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →BASF SE
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →CSPC Pharmaceutical Group Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Nutraceutical Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Gnosis by Lesaffre
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Jiangsu Yuyuan Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Luye Pharma Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Shandong Luwei Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,476M by 2033 · 11.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Lanolin-derived Vitamin D341.4
- Fish Oil-derived Vitamin D311.0
- Lichen-derived Vegan Vitamin D327.8
- Synthetic Vitamin D319.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$202.2M → $491.1M · 11.7%
Europe$140.9M → $315.0M · 10.6%
Asia Pacific$128.7M → $335.2M · 12.7%
Latin America$79.7M → $171.3M · 10.0%
Middle East and Africa$61.3M → $133.6M · 10.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.562026
11.582027
11.602028
11.612029
11.632030
11.632031
11.642032
11.652033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- DSM Nutritional Products9.0
- Kemin Industries10.3
- Fermenta Biotech Ltd.14.6
- Hubei Guangji Pharmaceutical Co. Ltd.14.4
- Jiangsu Yabang Dyestuff Co. Ltd.11.1
- Zhejiang NHU Co. Ltd.12.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Source16.0%
Form24.8%
Application27.0%
Purity Grade22.0%
Packaging Type10.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.0
- Europe21.8
- Asia Pacific23.2
- Latin America11.8
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| DSM Nutritional Products | 92 | 87 | 87 | 82 | 85 | 80 | 86 |
| Kemin Industries | 91 | 85 | 85 | 85 | 74 | 70 | 82 |
| Fermenta Biotech Ltd. | 78 | 76 | 70 | 74 | 70 | 69 | 73 |
| Hubei Guangji Pharmaceutical Co. Ltd. | 63 | 63 | 58 | 62 | 57 | 57 | 60 |
| Jiangsu Yabang Dyestuff Co. Ltd. | 61 | 77 | 72 | 74 | 72 | 68 | 71 |
| Zhejiang NHU Co. Ltd. | 52 | 46 | 51 | 46 | 46 | 66 | 51 |
| Jiangsu Kanion Pharmaceutical Co. Ltd. | 66 | 61 | 64 | 59 | 59 | 57 | 61 |
| BASF SE | 53 | 50 | 50 | 49 | 44 | 44 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- DSM Nutritional Products
- Kemin Industries
- Fermenta Biotech Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| DSM Nutritional Products | ◐ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Kemin Industries | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Fermenta Biotech Ltd. | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Hubei Guangji Pharmaceutical Co. Ltd. | ◐ | ◐ | − | ✓ | ◐ | ◐ |
| Jiangsu Yabang Dyestuff Co. Ltd. | − | ◐ | − | ✓ | ◐ | ◐ |
| Zhejiang NHU Co. Ltd. | ◐ | − | − | − | − | ✓ |
| Jiangsu Kanion Pharmaceutical Co. Ltd. | − | ✓ | ✓ | ◐ | ◐ | ◐ |
| BASF SE | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1DSM Nutritional Products86
2Kemin Industries82
3Fermenta Biotech Ltd.73
4Jiangsu Yabang Dyestuff Co. Ltd.71
5Jiangsu Kanion Pharmaceutical Co. Ltd.61
6Hubei Guangji Pharmaceutical Co. Ltd.60
7Zhejiang NHU Co. Ltd.51
8BASF SE48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
DSM Nutritional ProductsKemin Industries
Challenger2
Strong scale, closing on the leaders.
Fermenta Biotech Ltd.Jiangsu Yabang Dyestuff Co. Ltd.
Contender2
Focused players with pockets of strength.
Hubei Guangji Pharmaceutical Co. Ltd.Jiangsu Kanion Pharmaceutical Co. Ltd.
Niche2
Specialists in a single segment or region.
Zhejiang NHU Co. Ltd.BASF SE
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Source in North America, then scale across Vitamin D3 Powder Market — a $306M beachhead inside a $4.87B market.
Beachhead (SOM)$306Mobtainable near-term
Serviceable (SAM)$1.92Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Lanolin-derived Vitamin D3
Best fit — highest urgency & budget in Source.
Economic buyer76 fit
Fish Oil-derived Vitamin D3
Strong fit — clear ROI and a fast path to value.
End user69 fit
Lichen-derived Vegan Vitamin D3
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales48%
Partner / channel26%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Source leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Vitamin D3 Powder Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified25%
Evaluation15%
Closed-won5%
$18.2KCAC
$99KLTV
5.4:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Vitamin D3 Powder Market is a high-growth opportunity — $10.3B by 2033, compounding at 10.6%.
TAM · 2025$4.61Btoday
TAM · 2033$10.3Bforecast
CAGR10.6%2027–2033
Cumulative$64.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.3BTotal addressable market
SAM$3.76BServiceable available market
SOM$770MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.6% CAGR
Demand compounds through 2033, outpacing GDP across Source.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.3BLarge & growingTAM by 2033 at 10.6% CAGR
$3.76BServiceable nowreachable with today’s model
$770MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.02BBear6.9% CAGR
$10.3BBase10.6% CAGR
$13.2BBull13.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Vitamin D3 Powder Market — a $11.4B market by 2033. Plan: grow share from 6.0% to 12.7%.
Market size · 2033$11.4Btotal addressable
Market CAGR9.7%2027–2033
Target share12.7%from 6.0% today
Revenue ambition$1.44Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.0% | 12.7% | Ahead |
| Revenue | $748M | $1.44B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 33.8% | 44.5% | Behind |
| Customer retention | 87.2% | 94.1% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Source
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $153M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Source leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Vitamin D3 Powder Market conversation — a $5.26B market you can size, segment and defend in minutes.
Market size · 2033$5.26Btotal opportunity
Growth6.6%CAGR to 2033
Addressable buyers1,059+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source
Goal Grow share in Source
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 4 mopayback period
$51K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
DSM Nutritional ProductsKemin IndustriesFermenta Biotech Ltd.Hubei Guangji Pharmaceutical Co. Ltd.Jiangsu Yabang Dyestuff Co. Ltd.Zhejiang NHU Co. Ltd.Jiangsu Kanion Pharmaceutical Co. Ltd.BASF SE+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Vitamin D3 Powder Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Vitamin D3 Powder Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Complex Medical Disinfection Iodine Swab Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportVitamin D3 Oil Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportVitamin D Oil Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportHydrogel Dressing Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportBreast Cancer Therapeutics Drugs Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportChickenpox Varicella Vaccine Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportIrritable Bowel Syndrome with Constipation Drugs Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportUrological Cancer Therapeutics Drugs Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportLow Molecular Weight Heparin Sodium Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportGastro Esophageal Reflux Disease GERD Drug Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportCarboplatin Market
Market size, share, segmentation and regional forecast.
$670M market · 2025 base year
View reportMedical Grade Gels Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.